Fundraising FoxNanothermtx
1 known investors
Find your way into Nanothermtx
Sign up to find every way you can get introduced to Nanothermtx
- Your email: who you already know at Nanothermtx, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Nanothermtx team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Nanotherm Therapeutics develops a thermal ablation method for treating solid tumors, using nanoparticle activation to deliver targeted, contact-less heating in an image-guided, 2-step workflow. The approach is aimed at oncology treatment, delivering nanoparticles via a standard 19G needle and enabling same-day diagnosis and treatment.
Founders & leadership
AJ
Andreas JordanCEO & Founder
JL
Jan-Marc LieskovskyCBO
GS
Gernot SklenofskyCFO
Investors · 1
Related companies · 5
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Integrated Nanotherapeutics Inc.Integrated Nanotherapeutics develops lipid nanoparticle science and drug formulations for therapeutic applications. The company is led by scientists with over 100 years of collective expertise in preclinical research and drug development.
NanobiotixNanobiotix develops physics-based nanotherapeutics for cancer treatment, applying nanotechnology to expand therapeutic options for oncology patients. The company builds on French scientific research and targets patients worldwide through disruptive treatment approaches.
Nanoscope TherapeuticsNanoscope Therapeutics develops therapies for patients with complex retinal diseases that have high unmet need, including inherited retinal degenerations. The company focuses on treatments aimed at restoring vision in people affected by retinal blindness.
Nanobots TherapeuticsNanobots Therapeutics develops the MotionTx platform to create nanobots that penetrate tissues and enhance drug accumulation in target cells for therapeutic applications. The company is a spin-off of ICREA and IBEC resulting from research by Prof. Samuel Sánchez.
Companies working in the same space as Nanothermtx.
Frequently asked questions
- What does Nanothermtx do?
- Nanotherm Therapeutics develops a thermal ablation method for treating solid tumors, using nanoparticle activation to deliver targeted, contact-less heating in an image-guided, 2-step workflow. The approach is aimed at oncology treatment, delivering nanoparticles via a standard 19G needle and enabling same-day diagnosis and treatment.
- Who founded Nanothermtx?
- Nanothermtx was founded by Andreas Jordan.
- Who are Nanothermtx's investors?
- Nanothermtx's investors include The Innovation Space.